Notes
to Condensed Consolidated Financial Statements
(Unaudited)
1.
Nature of Operations and Basis of Presentation
Mobivity
Holdings Corp. (the “Company” or “we”) is in the business of developing and operating proprietary platforms
over which brands and enterprises can conduct national and localized, data-driven mobile marketing campaigns. Our proprietary
platforms, consisting of software available to phones, tablets, PCs, and Point of Sale (“POS”) systems, allow resellers,
brands and enterprises to market their products and services to consumers through text messages sent directly to consumers via
mobile phones, mobile smartphone applications, and dynamically printed receipt content. On November 14, 2018, we completed the
acquisition of certain operating assets relating to Belly, Inc.’s proprietary digital customer loyalty platform, including
client contracts, accounts receivable and intellectual property. We generate revenue by charging the resellers, brands and enterprises
a per-message transactional fee, through fixed or variable software licensing fees, or via advertising fees.
The
accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles
generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions
to Form 10-Q and Rule 8-03 of Regulation S-X promulgated by the Securities and Exchange Commission (“SEC”). Accordingly,
they do not include all of the information and disclosures required by GAAP for annual financial statements. The accompanying
unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements
and notes thereto in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 filed with the SEC on
March 30, 2020.
In
the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered
necessary for a fair presentation of our condensed consolidated financial statements as of September 30, 2020, and for the three
and nine months ended September 30, 2020 and 2019. The results of operations for the three and nine months ended September 30,
2020 are not necessarily indicative of the operating results for the full year ending December 31, 2020.
2.
Summary of Significant Accounting Policies
Principles
of Consolidation
The
consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany
balances and transactions have been eliminated.
Use
of Estimates
The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of expenses during the reporting period. Significant estimates used are those related to stock-based
compensation, asset impairments, the valuation and useful lives of depreciable tangible and certain intangible assets, the fair
value of common stock used in acquisitions of businesses, the fair value of assets and liabilities acquired in acquisitions of
businesses, and the valuation allowance of deferred tax assets. Management believes that these estimates are reasonable; however,
actual results may differ from these estimates.
Accounts
Receivable, Allowance for Doubtful Accounts and Concentrations
Accounts
receivable are carried at their estimated collectible amounts. We grant unsecured credit to substantially all of our customers.
Ongoing credit evaluations are performed, and potential credit losses are charged to operations at the time the account receivable
is estimated to be uncollectible. Since we cannot necessarily predict future changes in the financial stability of our customers,
we cannot guarantee that our reserves will continue to be adequate.
As
of September 30, 2020, and December 31, 2019, we recorded an allowance for doubtful accounts of $14,589 and $88,071, respectively.
Goodwill
and Intangible Assets
Goodwill
is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first
performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit
is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the reporting unit’s
carrying value is compared to its fair value. The fair values of the reporting units are estimated using market and discounted
cash flow approaches. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. The
discounted cash flow approach uses expected future operating results. Failure to achieve these expected results may cause a future
impairment of goodwill at the reporting unit.
Intangible
assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased
trade names, purchased technology, non-compete agreements, and software development costs. Intangible assets are amortized over
the period of estimated benefit using the straight-line method and estimated useful lives ranging from one to twenty years. No
significant residual value is estimated for intangible assets.
Software
Development Costs
Software
development costs include direct costs incurred for internally developed products and payments made to independent software developers
and/or contract engineers. The Company accounts for software development costs in accordance with the FASB guidance for the costs
of computer software to be sold, leased, or otherwise marketed (“ASC Subtopic 985-20”). Software development costs
are capitalized once the technological feasibility of a product is established and such costs are determined to be recoverable.
Technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed
and tested product design and working model. Software development costs are capitalized once technological feasibility of a product
is established and such costs are determined to be recoverable against future revenues. Technological feasibility is evaluated
on a project-by-project basis. Amounts related to software development that are not capitalized are charged immediately to the
appropriate expense account. Amounts that are considered ‘research and development’ that are not capitalized are immediately
charged to engineering, research, and development expense.
Capitalized
costs for those products that are cancelled or abandoned are charged to product development expense in the period of cancellation.
Commencing upon product release, capitalized software development costs are amortized to “Amortization Expense - Development”
based on the straight-line method over a twenty-four month period.
The
Company evaluates the future recoverability of capitalized software development costs on an annual basis. For products that have
been released in prior years, the primary evaluation criterion is ongoing relations with the customer.
Impairment
of Long-Lived Assets
We
evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that
the carrying amount of a long-lived asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds
the undiscounted future net cash flow the asset is expected to generate.
Foreign
Currency Translation
The
Company translates the financial statements of its foreign subsidiary from the local (functional) currency into US Dollars using
the year or reporting period end or average exchange rates in accordance with the requirements of Accounting Standards Codification
subtopic 830-10, Foreign Currency Matters (“ASC 830-10”). Assets and liabilities of these subsidiaries
were translated at exchange rates as of the balance sheet date. Revenues and expenses are translated at average rates in effect
for the periods presented. The cumulative translation adjustment is included in the accumulated other comprehensive gain (loss)
within shareholders’ equity. Foreign currency transaction gains and losses arising from exchange rate fluctuations on transactions
denominated in a currency other than the functional currency are included in the unaudited Condensed Consolidated Statements of
Income and Comprehensive Income.
Revenue
Recognition and Concentrations
Our
Recurrency platform is a hosted solution. We generate revenue from licensing our software to clients in our software as a service
model, per-message and per-minute transactional fees, and customized professional services. We recognize license/subscription
fees over the period of the contract, service fees as the services are performed, and per-message or per-minute transaction revenue
when the transaction takes place. Under Topic 606, revenue is recognized when control of the promised goods or services is transferred
to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services.
We consider authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit
of accounting. Some customers are billed on a month-to-month basis with no contractual term and are collected by credit card.
Revenue is recognized at the time that the services are rendered, and the selling price is fixed with a set range of plans. Cash
received in advance of the performance of services is recorded as deferred revenue.
Accounting
Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Accounting Standards Codification
606 (“ASC 606”), is a comprehensive revenue recognition standard that superseded nearly all existing revenue
recognition guidance. The Company adopted this standard effective January 1, 2018, applying the modified retrospective
method. Upon adoption, the Company discontinued revenue deferral under the sell-through model and commenced recording revenue
upon delivery to distributors, net of estimated returns. Generally, the new standard results in earlier recognition of
revenues.
We
determine revenue recognition under ASC 606 through the following steps:
|
●
|
identification
of the contract, or contracts, with a customer;
|
|
●
|
identification
of the performance obligations in the contract;
|
|
●
|
identification
of the transaction price;
|
|
●
|
allocation
of the transaction price to the performance obligations in the contract; and
|
|
●
|
recognition
of revenue when, or as, we satisfy a performance obligation.
|
During
the nine months ended September 30, 2020 and 2019, two customers accounted for 67% and 71% of our revenues, respectively.
Comprehensive
Income (Loss)
Comprehensive
loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources.
We are required to record all components of comprehensive loss in the consolidated financial statements in the period in which
they are recognized. Net loss and other comprehensive loss, including foreign currency translation adjustments and unrealized
gains and losses on investments, are reported, net of their related tax effect, to arrive at comprehensive loss. For the nine
months ended September 30, 2020 and 2019, the comprehensive loss was $1,710,743 and $6,315,165, respectively.
Net
Loss Per Common Share
Basic
net loss per share excludes any dilutive effects of options, shares subject to repurchase and warrants. Diluted net loss per share
includes the impact of potentially dilutive securities. During the three and nine months ended September 30, 2019 and the
nine months ended September 30, 2020, we had securities outstanding which could potentially dilute basic earnings per
share in the future. Those were excluded from the computation of diluted net loss per share when their effect would have been
anti-dilutive.
Reclassifications
Certain
amounts from prior periods have been reclassified to conform to the current period presentation.
Recent
Accounting Pronouncements
Accounting
standards promulgated by the FASB are subject to change. Changes in such standards may have an impact on the Company’s future
financial statements. The following are a summary of recent accounting developments.
In
February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)
2016-02, “Leases (Topic 842)”. Under this guidance, an entity is required to recognize right-of-use assets and lease
liabilities on its balance sheet and disclose key information about leasing arrangements. This guidance offers specific accounting
guidance for a lessee, a lessor and sale and leaseback transactions. Lessees and lessors are required to disclose qualitative
and quantitative information about leasing arrangements to enable a user of the financial statements to assess the amount, timing
and uncertainty of cash flows arising from leases. This guidance is effective for annual reporting periods beginning after December
15, 2018, including interim periods within that reporting period, and requires a modified retrospective adoption, with early adoption
permitted. The Company adopted this standard as of January 1, 2019.
In
January 2017, the FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment, which removes the second step of the
two-step goodwill impairment test. Under ASU 2017-04, an entity will apply a one-step quantitative test and record the amount
of goodwill impairment as the excess of a reporting unit’s carrying amount over its fair value, not to exceed the total
amount of goodwill allocated to the reporting unit. ASU 2017-04 does not amend the optional qualitative assessment of goodwill
impairment. Additionally, an entity should consider income tax effects from any tax-deductible goodwill on the carrying amount
of the reporting unit when measuring the goodwill impairment loss, if applicable. ASU 2017-04 is effective for annual or any interim
goodwill impairment tests in fiscal years beginning after December 15, 2019; early adoption is permitted for interim or annual
goodwill impairment tests performed on testing dates after January 1, 2017. The Company adopted this standard as of January 1,
2020.
3.
Goodwill and Purchased Intangibles
Goodwill
The
carrying value of goodwill at September 30, 2020 and December 31, 2019 was $496,352.
The
following table presents details of our purchased intangible assets as of September 30, 2020 and December 31, 2019:
Intangible
assets
|
|
Balance at
December 31,
2019
|
|
|
Additions
|
|
|
Impairments
|
|
|
Amortization
|
|
|
Fx and Other
|
|
|
Balance at
September 30,
2020
|
|
Patents and trademarks
|
|
$
|
69,853
|
|
|
$
|
8,755
|
|
|
$
|
(3,481
|
)
|
|
$
|
(9,484
|
)
|
|
$
|
(92
|
)
|
|
$
|
65,551
|
|
Customer and merchant relationships
|
|
|
739,236
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(72,639
|
)
|
|
|
-
|
|
|
|
666,597
|
|
Trade name
|
|
|
50,732
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(6,959
|
)
|
|
|
(10
|
)
|
|
|
43,763
|
|
Acquired technology
|
|
|
144,792
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(12,225
|
)
|
|
|
-
|
|
|
|
132,567
|
|
Non-compete agreements
|
|
|
60,931
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(11,895
|
)
|
|
|
-
|
|
|
|
49,036
|
|
|
|
$
|
1,065,544
|
|
|
$
|
8,755
|
|
|
$
|
(3,481
|
)
|
|
$
|
(113,202
|
)
|
|
$
|
(102
|
)
|
|
$
|
957,514
|
|
The
intangible assets are being amortized on a straight-line basis over their estimated useful lives of one to twenty years.
Amortization
expense for intangible assets was $37,758 and $37,779 for the three months ended September 30, 2020 and 2019, respectively.
Amortization
expense for intangible assets was $113,202 and $113,309 for the nine months ended September 30, 2020 and 2019, respectively.
The
estimated future amortization expense of our intangible assets as of September 30, 2020 is as follows:
Year ending December 31,
|
|
Amount
|
|
2020
|
|
$
|
37,732
|
|
2021
|
|
|
148,240
|
|
2022
|
|
|
148,114
|
|
2023
|
|
|
145,606
|
|
2024
|
|
|
109,010
|
|
Thereafter
|
|
|
368,812
|
|
Total
|
|
$
|
957,514
|
|
4.
Software Development Costs
The
Company has capitalized certain costs for software developed or obtained for internal use during the application development stage
as it relates to specific contracts. The amounts capitalized include external direct costs of services used in developing internal-use
software and for payroll and payroll-related costs of employees directly associated with the development activities
The
following table presents details of our software development costs as of September 30, 2020 and December 31, 2019:
|
|
Balance at
December 31,
2019
|
|
|
Additions
|
|
|
Amortization
|
|
|
Balance at
September 30,
2020
|
|
Software Development Costs
|
|
$
|
696,667
|
|
|
$
|
196,997
|
|
|
$
|
(402,211
|
)
|
|
$
|
491,453
|
|
|
|
$
|
696,667
|
|
|
$
|
196,997
|
|
|
$
|
(402,211
|
)
|
|
$
|
491,453
|
|
Software
development costs are being amortized on a straight-line basis over their estimated useful life of two years.
Amortization
expense for software development costs was $141,196 and $107,258 for the three months ended September 30, 2020 and 2019, respectively.
Amortization
expense for software development costs was $402,211 and $318,280 for the nine months ended September 30, 2020 and 2019, respectively.
The
estimated future amortization expense of software development costs as of September 30, 2020 is as follows:
Year ending December 31,
|
|
Amount
|
|
2020
|
|
$
|
115,894
|
|
2021
|
|
|
315,589
|
|
2022
|
|
|
59,970
|
|
2023
|
|
|
-
|
|
2024
|
|
|
-
|
|
Thereafter
|
|
|
-
|
|
Total
|
|
$
|
491,453
|
|
5.
Operating Lease Assets
Adoption
of Accounting Standards Codification (“ASC”) Topic 842, “Leases.” The Company adopted Topic 842
on January 1, 2019, using the modified retrospective method and the optional transition method to record the adoption impact through
a cumulative adjustment to equity. Results for reporting periods beginning after January 1, 2019, are presented under Topic 842,
while prior periods are not adjusted and continue to be reported under the accounting standards in effect for those periods.
The
following are additional details related to leases recorded on our balance sheet as of September 30, 2020:
Leases
|
|
Classification
|
|
Balance at
September 30,
2020
|
|
Assets
|
|
|
|
|
|
|
Current
|
|
|
|
|
|
|
Operating lease assets
|
|
Operating lease assets
|
|
$
|
98,027
|
|
Noncurrent
|
|
|
|
|
|
|
Operating lease assets
|
|
Noncurrent operating lease assets
|
|
$
|
18,083
|
|
Total lease assets
|
|
|
|
$
|
116,110
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
Current
|
|
|
|
|
|
|
Operating lease liabilities
|
|
Operating lease liabilities
|
|
$
|
126,318
|
|
Noncurrent
|
|
|
|
|
|
|
Operating lease liabilities
|
|
Noncurrent operating lease liabilities
|
|
$
|
23,075
|
|
Total lease liabilities
|
|
|
|
$
|
149,393
|
|
The
maturity analysis below summarizes the remaining future undiscounted cash flows for our operating leases, a reconciliation to
operating lease liabilities reported on the Condensed Consolidated Balance Sheet, our weighted-average remaining lease term and
weighted average discount rate:
Year ending December 31,
|
|
Amount
|
|
2020
|
|
$
|
79,954
|
|
2021
|
|
|
60,592
|
|
2022
|
|
|
13,484
|
|
2023
|
|
|
-
|
|
2024
|
|
|
-
|
|
Thereafter
|
|
|
-
|
|
Total future lease payments
|
|
|
154,030
|
|
Less: imputed interest
|
|
|
(4,637
|
)
|
Total
|
|
$
|
149,393
|
|
Weighted Average Remaining Lease Term (years)
|
|
|
|
|
Operating leases
|
|
|
1
|
|
|
|
|
|
|
Weighted Average Discount Rate
|
|
|
|
|
Operating leases
|
|
|
6.75
|
%
|
6.
Notes Payable and Interest Expense
The
following table presents details of our notes payable as of September 30, 2020 and December 31, 2019:
Facility
|
|
Maturity
|
|
Interest Rate
|
|
|
Balance at
September 30,
2020
|
|
|
Balance at
December 31,
2019
|
|
BDC Term Loan
|
|
October 15, 2021
|
|
|
25
|
%
|
|
$
|
188,306
|
|
|
$
|
224,307
|
|
ACOA Note
|
|
May 1, 2023
|
|
|
-
|
|
|
|
106,095
|
|
|
|
117,131
|
|
Wintrust Bank
|
|
November 1, 2021
|
|
|
Prime + 1.5
|
%
|
|
|
466,667
|
|
|
|
766,667
|
|
TD Bank
|
|
December 31, 2022
|
|
|
-
|
|
|
|
29,890
|
|
|
|
-
|
|
Chase Bank
|
|
April 10, 2022
|
|
|
1
|
%
|
|
|
891,103
|
|
|
|
-
|
|
Related Party Note
|
|
various
|
|
|
15
|
%
|
|
|
1,280,000
|
|
|
|
1,140,700
|
|
Total Debt
|
|
|
|
|
|
|
|
|
2,962,061
|
|
|
|
2,248,805
|
|
Less current portion
|
|
|
|
|
|
|
|
|
(644,021
|
)
|
|
|
(681,276
|
)
|
Long-term debt, net of current portion
|
|
|
|
|
|
|
|
$
|
2,318,040
|
|
|
$
|
1,567,529
|
|
BDC
Term Loan
On
January 8, 2016, Livelenz, a wholly-owned subsidiary of the Company (“Livelenz”), entered into an amendment of their
original loan agreement dated August 26, 2011 with the Business Development Bank of Canada (“BDC”). Under this agreement
the loan would have matured, and the commitments would have terminated on September 15, 2019.
On
July 26, 2019, Livelenz, entered into an amendment of their original loan agreement dated August 26, 2011 with the Business Development
Bank of Canada (“BDC”). Under this agreement the loan will mature, and the commitments will terminate on October 15,
2021. In accordance with the amendment, the Company will commence monthly payments beginning on August 15, 2019 of principal in
the amount of $8,500 in addition to the monthly payment of accrued interest. These payments will increase to $10,000 on November
15, 2019, $12,000 on May 15, 2020, $14,000 on November 15, 2020 and $16,000 on May 15, 2021 in addition to the monthly interest.
During the nine months ended September 30, 2020 we repaid $36,001 of principal.
ACOA
Note
On
November 6, 2017, Livelenz (a wholly-owned subsidiary of the Company), entered into an amendment of the original agreement dated
December 2, 2014 with the Atlantic Canada Opportunities Agency (“ACOA”). Under this agreement the note will mature,
and the commitments will terminate on May 1, 2023. The monthly principal payment amount of $3,000 increased to $3,500 beginning
on November 1, 2019, $4,000 on November 1, 2020, $4,500 on November 1, 2021 and $2,215 during the remaining term of the agreement.
During the nine months ended September 30, 2020 we repaid $11,036 of principal.
Wintrust
Loan
On
November 14, 2018, the Company entered into a Loan and Security Agreement with Wintrust Bank. The Loan and Security Agreement
provides for a single-term loan to us in the original principal amount of $1,000,000. Interest accrues on the unpaid principal
amount at the rate of prime plus 1.5%. The loan is a three-year loan and is interest-only payable for the first six months of
the loan. Commencing on May 1, 2019, the Company will commence monthly payments of principal in the amount of $33,333 in addition
to the monthly payment of accrued interest. The loan is secured by all of our assets other than our intellectual property. We
used the proceeds of the loan to re-finance a loan in the principal amount of $1,000,000 we assumed as part of the acquisition
of the Belly assets.
On
August 7, 2020, the Company entered into an amendment of their original loan agreement dated November 14, 2018 with Wintrust Bank.
Under this agreement the covenant calculation was amended to calculate covenants under a borrowing base methodology. The Company
had defaulted under the March 31, 2020 and June 30 ,2020 covenants which were waived upon execution of the amendment and the
Company has not committed any defaults under loan agreement subsequent to the amendment. During the nine months ended September
30, 2020 we repaid $300,000 of principal.
Chase
Loan
On
April 10, 2020, we entered into a commitment loan with Chase Bank, N.A. under the CARES act and SBA Paycheck Protection Program,
in the principal aggregate amount of $891,103, which is due and payable two years after issuance. This note bears interest
on the unpaid balance at the rate of one percent (1%) per annum. The note contains a deferral period of six months, for which
no interest or principal payments are due. Forgiveness of the loan may be obtained by meeting certain SBA requirements.
TD
Bank Loan
On
April 22, 2020, we entered into a commitment loan with TD Bank under the Canadian Emergency Business Account (“CEBA”),
in the principal aggregate amount of $40,000 CAD, which is due and payable on December 31, 2022. This note bears interest
on the unpaid balance at the rate of zero percent (0%) per annum during the initial term. Under this note no interest or principal
payments are due until January 1, 2023. Under the conditions of the loan, twenty-five percent (25%) of the loan will be forgiven
if seventy-five percent (75%) is repaid prior to the initial term date.
Related
Party Notes
During
February 2018, we conducted a private placement of Unsecured Promissory Notes (individually, a “Note” and collectively,
the “Notes”) in the aggregate principal amount of $1,080,000 to certain investors, officers and directors of
the Company. Each Note bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum and the principal and
accrued interest is due and payable no later than December 1, 2020. We may prepay any of the Notes without notice, subject to
a two percent (2%) pre-payment penalty. The Note offer was conducted by our management and there were no commissions paid by us
in connection with the solicitation.
During
the year ended December 31, 2019 we issued unsecured notes in the principle aggregate amount of $3,500,000, which become due two
years after the date of issuance. These notes bear interest on the unpaid balance at the rate of fifteen percent (15%) per annum.
The Company may prepay any of the Notes without notice, subject to a two percent (2%) pre-payment penalty.
On
July 2, 2019, a total of $2,500,000 of principal under the above-mentioned notes and the accrued interest of $82,916 was converted
into equity and we recorded a loss on conversion of debt of $232,462 for the year ended December 31, 2019.
On
February 26, 2020, we issued an unsecured note in the principle aggregate amount of $200,000, which becomes due two years after
the date of issuance. This note bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company
may prepay this note without notice, subject to a two percent (2%) pre-payment penalty.
As
of September 30, 2020, we have a principal balance of $1,280,000 and accrued interest of $176,675 outstanding.
Interest
Expense
Interest
expense was $62,621 and $57,569 during the three months ended September 30, 2020 and 2019, respectively.
Interest
expense was $207,899 and $188,451 during the nine months ended September 30, 2020 and 2019, respectively.
7.
Stockholders’ Equity
Common
Stock
2019
In
July 2019, the Company commenced a private placement of its common stock units, with each unit consisting of one share of our
common stock and a warrant to purchase to one-half share of our common stock at an exercise price of $1.25 per share at an offering
price of $1.00 per unit. The Company sold 2,800,000 units of its common stock for gross proceeds of $2,800,000. In addition, the
Company issued 2,582,916 units of its common stock associated with the conversion of $2,500,000 of principal, $82,916 of accrued
interest, and a loss on conversion of $232,462 (See Note 6).
2020
On
March 2, 2020, the Company issued 234,500 shares of common stock in exchange for cash in conjunction with a warrant exercise.
The shares were exercised at the strike price of $1.00 per share.
On
September 17, 2020, the Company issued 15,000 shares of common stock in exchange for cash in conjunction with a stock option exercise.
The shares were exercised at the strike price of $0.48 per share.
As
of September 30, 2020 and December 31, 2019 we had an equity payable balance of $100,862.
Stock-based
Plans
Stock
Option Activity
The
following table summarizes stock option activity for the year ended December 31, 2019 and for the nine months ended September
30, 2020:
|
|
Options
|
|
Outstanding at December 31, 2018
|
|
|
4,987,426
|
|
Granted
|
|
|
2,592,500
|
|
Exercised
|
|
|
-
|
|
Forfeit/canceled
|
|
|
(923,389
|
)
|
Expired
|
|
|
(874,653
|
)
|
Outstanding at December 31, 2019
|
|
|
5,781,884
|
|
Granted
|
|
|
715,000
|
|
Exercised
|
|
|
(15,000
|
)
|
Forfeit/canceled
|
|
|
(579,695
|
)
|
Expired
|
|
|
(438,127
|
)
|
Outstanding at September 30, 2020
|
|
|
5,464,062
|
|
The
weighted average exercise price of stock options granted during the period was $0.70 and the related weighted average grant date
fair value was $0.47 per share.
2019
On
January 7, 2019, the Company granted one employee a total of 10,000 options to purchase shares of the Company common stock at
the closing price as of January 7, 2019 of $1.17 per share. The Option Shares will vest ratably over forty-eight (48) months and
are exercisable until January 7, 2029. The total estimated value using the Black-Scholes Model, based on a volatility rate of
90.82% and an option fair value of $.88 was $8,821.
On
January 21, 2019, the Company granted one employee a total of 15,000 options to purchase shares of the Company common stock at
the closing price as of January 21, 2019 of $1.17 per share. The Option Shares will vest ratably over forty-eight (48) months
and are exercisable until January 21, 2029. The total estimated value using the Black-Scholes Model, based on a volatility rate
of 90.75% and an option fair value of $.88 was $13,239.
On
February 12, 2019, the Company granted one employee a total of 150,000 options to purchase shares of the Company common stock
at the closing price as of February 12, 2019 of $1.00 per share. The Option Shares will vest ratably over forty-eight (48) months
and are exercisable until February 12, 2029. The total estimated value using the Black-Scholes Model, based on a volatility rate
of 90.79% and an option fair value of $.75 was $113,046.
On
February 18, 2019, the Company granted one employee a total of 15,000 options to purchase shares of the Company common stock at
the closing price as of February 18, 2019 of $1.05 per share. The Option Shares will vest ratably over forty-eight (48) months
and are exercisable until February 18, 2029. The total estimated value using the Black-Scholes Model, based on a volatility rate
of 90.88% and an option fair value of $.84 was $12,537.
On
February 25, 2019, the Company granted one employee a total of 50,000 options to purchase shares of the Company common stock at
the closing price as of February 25, 2019 of $1.00 per share. The Option Shares will vest ratably over forty-eight (48) months
and are exercisable until February 25, 2029. The total estimated value using the Black-Scholes Model, based on a volatility rate
of 90.88% and an option fair value of $.75 was $37,697.
On
March 11, 2019, the Company granted one employee a total of 50,000 options to purchase shares of the Company common stock at the
closing price as of March 11, 2019 of $1.00 per share. The Option Shares will vest ratably over forty-eight (48) months and are
exercisable until March 11, 2029. The total estimated value using the Black-Scholes Model, based on a volatility rate of 90.90%
and an option fair value of $.75 was $37,688.
On
May 17, 2019, the Company granted three employees a total of 1,775,000 options to purchase shares of the Company common stock
at the closing price as of May 17, 2019 of $1.04 per share. The Option Shares will vest ratably over forty-eight (48) months and
are exercisable until May 17, 2029. The total estimated value using the Black-Scholes Model, based on a volatility rate of 80.17%
and an option fair value of $.72 was $1,283,178.
On
August 21, 2019, the Company granted four employees a total of 140,000 options to purchase shares of the Company common stock
at the closing price as of August 21, 2019 of $0.95 per share. The Option Shares will vest 25% on the first anniversary of the
grant, then equally in 36 monthly installments thereafter and are exercisable until August 21, 2029. The total estimated value
using the Black-Scholes Model, based on a volatility rate of 80.17% and an option fair value of $.65 was $91,537.
On
October 21, 2019, the Company granted one employee 150,000 options to purchase shares of the Company common stock at the closing
price as of October 21, 2019 of $0.98 per share. The Option Shares will vest 25% on the first anniversary of the grant, then equally
in 36 monthly installments thereafter and are exercisable until October 21, 2029. The total estimated value using the Black-Scholes
Model, based on a volatility rate of 74.18% and an option fair value of $.64 was $96,165.
On
November 19, 2019, the Company granted twelve employees a total of 237,500 options to purchase shares of the Company common stock
at the closing price as of November 19, 2019 of $0.88 per share. The Option Shares will vest 25% on the first anniversary of the
grant, then equally in 36 monthly installments thereafter and are exercisable until November 19, 2029. The total estimated value
using the Black-Scholes Model, based on a volatility rate of 78.70% and an option fair value of $.60 was $142,409.
2020
On
March 24, 2020, the Company granted one employee a total of 15,000 options to purchase shares of the Company common stock at the
closing price as of March 24, 2020 of $0.65 per share. The Option Shares will vest 25% on the first anniversary of the grant,
then equally in 36 monthly installments thereafter and are exercisable until March 24, 2030. The total estimated value using the
Black-Scholes Model, based on a volatility rate of 77.56% and an option fair value of $.43 was $6,472.
On
April 6, 2020, the Company granted four employees a total of 700,000 options to purchase shares of the Company common stock at
the closing price as of April 6, 2020 of $0.70 per share. The Option Shares will vest 25% on the first anniversary of the grant,
then equally in 36 monthly installments thereafter and are exercisable until April 6, 2030. The total estimated value using the
Black-Scholes Model, based on a volatility rate of 78.21% and an option fair value of $.47 was $326,752.
Stock-Based
Compensation Expense from Stock Options and Warrants
The
impact on our results of operations of recording stock-based compensation expense for the three and nine months ended September
30, 2020 and 2019 were as follows:
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
September 30,
|
|
|
September 30,
|
|
|
|
2020
|
|
|
2019
|
|
|
2020
|
|
|
2019
|
|
General and administrative
|
|
$
|
61,081
|
|
|
$
|
94,122
|
|
|
$
|
197,778
|
|
|
$
|
584,160
|
|
Sales and marketing
|
|
|
20,914
|
|
|
|
13,020
|
|
|
|
55,512
|
|
|
|
63,575
|
|
Engineering, research, and development
|
|
|
39,460
|
|
|
|
40,607
|
|
|
|
125,922
|
|
|
|
111,567
|
|
|
|
$
|
121,455
|
|
|
$
|
147,749
|
|
|
$
|
379,212
|
|
|
$
|
759,302
|
|
Valuation
Assumptions
The
fair value of each stock option award was calculated on the date of grant using the Black-Scholes option pricing model. The following
weighted average assumptions were used for the nine months ended September 30, 2020 and 2019.
|
|
Nine Months Ended
|
|
|
|
September 30,
|
|
|
|
2020
|
|
|
2019
|
|
Risk-free interest rate
|
|
|
0.49
|
%
|
|
|
2.21
|
%
|
Expected life (years)
|
|
|
6.00
|
|
|
|
6.00
|
|
Expected dividend yield
|
|
|
-
|
%
|
|
|
-
|
%
|
Expected volatility
|
|
|
78.20
|
%
|
|
|
81.57
|
%
|
The
risk-free interest rate assumption is based upon published interest rates appropriate for the expected life of our employee stock
options.
The
expected life of the stock options represents the weighted-average period that the stock options are expected to remain outstanding
and was determined based on historical experience of similar awards, giving consideration to the contractual terms of the stock-based
awards, vesting schedules and expectations of future employee behavior as influenced by changes to the terms of its stock-based
awards.
The
dividend yield assumption is based on our history of not paying dividends and no future expectations of dividend payouts.
The
expected volatility in 2020 and 2019 is based on the historical publicly traded price of our common stock.
Restricted
stock units
The
following table summarizes restricted stock unit activity under our stock-based plans for the year ended December 31, 2019
and for the nine months ended September 30, 2020:
|
|
Shares
|
|
Outstanding at December 31, 2018
|
|
|
662,800
|
|
Awarded
|
|
|
489,448
|
|
Released
|
|
|
-
|
|
Canceled/forfeited/expired
|
|
|
-
|
|
Outstanding at December 31, 2019
|
|
|
1,152,248
|
|
Awarded
|
|
|
181,252
|
|
Released
|
|
|
-
|
|
Canceled/forfeited/expired
|
|
|
-
|
|
Outstanding at September 30, 2020
|
|
|
1,333,500
|
|
|
|
|
|
|
Expected to vest at September 30, 2020
|
|
|
1,333,500
|
|
Vested at September 30, 2020
|
|
|
1,333,500
|
|
Unvested at September 30, 2020
|
|
|
-
|
|
Unrecognized expense at September 30, 2020
|
|
$
|
-
|
|
2019
On
January 1, 2019, the Company issued to four independent directors a total of 222,224 restricted stock units. These restricted
stock units were issued for the $260,000 of board compensation earned in 2018. The units were valued at $260,000 or $1.17 per
share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated
with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) a
change in control of the Company, and (B) the termination of the director’s service with the Company.
On
March 31, 2019, the Company granted four independent directors a total of 72,224 restricted stock units. The units were valued
at $65,001 or $0.90 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares
of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the
earliest to occur of (A) a change in control of the Company, and (B) the termination of the director’s service with the
Company.
On
December 31, 2019, the Company granted four independent directors a total of 195,000 restricted stock units. The units were valued
at $195,000 or $1.00 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares
of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the
earliest to occur of (A) a change in control of the Company, and (B) the termination of the director’s service with the
Company.
2020
On
March 24, 2020, the Company granted four independent directors a total of 100,000 restricted stock units. The units were valued
at $65,000 or $0.65 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares
of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the
earliest to occur of (A) a change in control of the Company, and (B) the termination of the director’s service with the
Company.
On
August 7, 2020, the Company granted four independent directors a total of 81,252 restricted stock units. The units were valued
at $65,002 or $0.80 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares
of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the
earliest to occur of (A) a change in control of the Company, and (B) the termination of the director’s service with the
Company.
Stock
Based Compensation from Restricted Stock
The
impact on our results of operations of recording stock-based compensation expense for restricted stock units for the three and
nine months ended September 30, 2020 and 2019 was as follows:
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
September 30,
|
|
|
September 30,
|
|
|
|
2020
|
|
|
2019
|
|
|
2020
|
|
|
2019
|
|
General and administrative
|
|
$
|
65,002
|
|
|
$
|
-
|
|
|
$
|
130,002
|
|
|
$
|
65,001
|
|
|
|
$
|
65,002
|
|
|
$
|
-
|
|
|
$
|
130,002
|
|
|
$
|
65,001
|
|
As
of September 30, 2020, there was no unearned restricted stock unit compensation.
Warrants
Issued to Investors and Placement Agents
At
September 30, 2020, we have outstanding warrants to purchase 2,691,459 at $1.25 per share. These warrants expire in 2021.
8.
Fair Value Measurements
Fair
value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability
in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined
based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions,
the authoritative guidance establishes a three-tier value hierarchy, which prioritizes the inputs used in measuring fair value
as follows: (Level 1) observable inputs such as quoted prices in active markets; (Level 2) inputs other than the quoted prices
in active markets that are observable either directly or indirectly; and (Level 3) unobservable inputs in which there is little
or no market data, which requires us to develop our own assumptions. This hierarchy requires companies to use observable market
data, when available, and to minimize the use of unobservable inputs when determining fair value. On a recurring basis, we measure
certain financial assets and liabilities at fair value.
The
following table presents assets that are measured and recognized at fair value as of September 30, 2020 on a recurring and non-recurring
basis:
Description
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Gains (Losses)
|
|
Goodwill (non-recurring)
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
496,352
|
|
|
$
|
-
|
|
Intangibles, net (non-recurring)
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
1,448,967
|
|
|
$
|
-
|
|
The
following table presents assets that are measured and recognized at fair value as of December 31, 2019 on a recurring and non-recurring
basis:
Description
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Gains (Losses)
|
|
Goodwill (non-recurring)
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
496,352
|
|
|
$
|
-
|
|
Intangibles, net (non-recurring)
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
1,762,211
|
|
|
$
|
-
|
|
9.
Commitments and Contingencies
Litigation
As
of the date of this report, there are no pending legal proceedings to which we or our properties are subject, except for routine
litigation incurred in the normal course of business.
Operating
Lease
As
described in Note 5, the Company has a lease agreement for 10,395 square feet, for its office facilities in Chandler, AZ through
January 2021. Monthly rental payments, including common area maintenance charges, are $19,707, to $20,140. As of September
30, 2020, we have an operating lease asset balance for this lease of $69,075 and an operating lease liability balance for this
lease of $88,809 recorded in accordance with ASC 842
The
Company also has a lease through April 2022 for 3,248 square feet of office space located in Halifax, Nova Scotia, at a monthly
rental expense of $2,665 to $3,371 per month, excluding common area maintenance charges. As of September 30, 2020, we have an
operating lease asset balance for this lease of $47,035 and an operating lease liability balance for this lease of $60,584 recorded
in accordance with ASC 842.
10.
Related Party Transactions
Unsecured
Promissory Note Investments in 2019
During
the year ended December 31, 2019, we issued to one of our directors, unsecured notes in the principal aggregate amount of $3,500,000,
which are due and payable two years after issuance. These notes bear interest on the unpaid balance at the rate of fifteen
percent (15%) per annum. The Company may prepay any of the Notes without notice, subject to a two percent (2%) pre-payment penalty.
We conducted the private placement of our securities in July 2019. The note holder participated in the private placement
by converting principal of $2,500,000 and accrued interest under the notes totaling $82,916, into 2,582,916 units of our securities.
As of September 30, 2020, we have $1,000,000 as a remaining balance of these notes and accrued interest of $128,125.
Unsecured
Promissory Note Investments in 2020
On
February 26, 2020, we issued to one of our directors, unsecured notes in the principal aggregate amount of $200,000, which are
due and payable two years after issuance. This notes bear interest on the unpaid balance at the rate of fifteen percent (15%)
per annum. The Company may prepay any of the Notes without notice, subject to a two percent (2%) pre-payment penalty. As of September
30, 2020, we have $200,000 as a remaining balance of these notes and accrued interest of $18,083.
11.
Subsequent Events
None